pipeline-prospector-insert-v1
X

Overview of Diphenhydramine

Client Email Product
NCGC00024414-06
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

Dossiers Market Place

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

0

SERVICES
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Ingredient(s): Lauryl Sulfate
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories
Ingredient(s): Stearic Acid
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Ready-to-use direct compression solution for tablets.
Ingredient(s): Crospovidone
Dosage Form: Granule / Pellet, Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Ingredient(s): Povidone
Dosage Form: Granule / Pellet, Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)
Ingredient(s): Polyvinyl Acetate
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.
Ingredient(s): Povidone
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Tablet binding, Thickener, Stabilizers of suspensions, Reduces sedimentation, crystallization inhibition.
Ingredient(s): Povidone
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone
Technical Specifications: Not Available
    Applications: HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.
    Dosage Form: Tablet
    More Info on Category: Direct Compression, Granulation
    Route of Administration (Grade): Oral
    Pharmacopoeia Reference: Not Available
    Technical Specifications: Not Available
      Applications: HiCel acts as a strong & dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
      Dosage Form: Tablet
      Route of Administration (Grade): Oral
      Pharmacopoeia Reference: Not Available
      Technical Specifications: Not Available
      Ask Us for Pharmaceutical Supplier and Partner
      Ask Us, Find A Supplier / Partner
      No Commissions, No Strings Attached, Get Connected for FREE

      What are you looking for?

      How can we help you?

      The request can't be empty

      Please read our Privacy Policy carefully

      You must agree to the privacy policy

      The name can't be empty
      The company can't be empty.
      The email can't be empty Please enter a valid email.
      The mobile can't be empty

      Advertise With Us

      Advertise With Us